Virginia Steen is a Rheumatology/Immunology physician affiliated with Georgetown University. OpenAlex indexes 359 publications with 40,347 citations (h-index 96); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- IVIG Treatment in Systemic Sclerosis
Sponsor: Georgetown University
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Sponsor: Georgetown University
- Placebo Controlled Trial of Bosentan in Scleroderma Patients
Sponsor: Georgetown University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
35.9%Corticosteroid17.5%Prednisone100%Part D≥28 patientsProton pump inhibitor15.4%Pantoprazole Sodium56%Omeprazole28%Esomeprazole Magnesium16%Part D<11 patients+ 1 more class in this area
Cancer & immunology
23%Folate Analog Metabolic Inhibitor11.1%Methotrexate100%Part D≥20 patientsTNF inhibitor7.5%Humira(Cf) Pen60%Enbrel Sureclick41%Part D<11 patients+ 2 more classes in this area
Cardiovascular
15.7%Calcium channel blocker13.2%Amlodipine Besylate72%Nifedipine Er28%Part D<11 patientsEndothelin Receptor Antagonist2.5%Opsumit100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2004–2009 per NIH RePORTER. The latest:
- BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE
Georgetown University
FY2009$3,452M01RR023942
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Augusto Pichard, MD
Georgetown University
Joseph Verbalis
Georgetown University
Craig Kessler
Georgetown University
Princy Kumar
Georgetown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”